Epigenetic markers of early tumor development

Methods in Molecular Biology
Ramona G Dumitrescu

Abstract

Cancer patients' outcome and survival depends on the early diagnosis of malignant lesions. Several investigation methods used for the prevention and early detection strategies have specific limitations. More recently, epigenetic changes have been considered one of the most promising tools for the early diagnosis of cancer. Some of these epigenetic alterations including promoter hypermethylation of genes like P16INK4a, BRCA1, BRCA2, ERα and RARβ2, APC, and RASSF1A have been associated with early stages of mammary gland tumorigenesis and have been suggested to be included in the models that evaluate individual breast cancer risk. In lung cancer, P16INK4a and MGMT gene hypermethylation was observed in sputum years before clinical manifestation of the squamous cell carcinoma among smokers. Loss of GSTP1 function by DNA hypermethylation together with changes in the methylation levels of repetitive elements like LINE-1 and Sat2 was reported in prostatic preneoplastic lesions. Also, DNA hypermethylation for hMLH1 and MGMT DNA repair genes was reported in precursor lesions to colorectal cancer. These epigenetic alterations may be influenced by factors such as xenoestrogens, folate, and multivitamins. Detection of these changes may help...Continue Reading

Citations

Nov 22, 2013·Breast Cancer Research and Treatment·Liang WuCheng Lu
Jul 26, 2013·World Journal of Gastroenterology : WJG·Piotr M WierzbickiZbigniew Kmiec
Oct 22, 2014·Epigenomics·Marjolaine NgolloDominique J Bernard-Gallon
Feb 26, 2015·Journal of Immunoassay & Immunochemistry·Laura Georgiana NeculaCarmen C Diaconu
Apr 2, 2014·Translational Research : the Journal of Laboratory and Clinical Medicine·Scott M LangevinKarl T Kelsey
Apr 10, 2013·The Journal of International Medical Research·Ying-Li LinZhi-Gang Li
Dec 1, 2017·Journal of Cell Communication and Signaling·Vijayalaxmi GuptaSushanta K Banerjee
Jan 17, 2013·The Journal of International Medical Research·Y L LinJ G Ma
Jul 25, 2018·Journal of Cellular and Molecular Medicine·Qiuyu LinChenghe Lin
May 18, 2013·Integrative Biology : Quantitative Biosciences From Nano to Macro·Pierre-Alexandre VidiSophie A Lelièvre
Nov 14, 2014·British Journal of Cancer·R PintoS Tommasi
Jun 6, 2014·Chemical Society Reviews·Yulia V Gerasimova, Dmitry M Kolpashchikov
Jul 22, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Wen LiJian-Xin Tang
Nov 16, 2012·International Journal of Oncology·Yasuko KitagishiSatoru Matsuda
Nov 21, 2013·Cancers·Antje M RichterReinhard H Dammann
Nov 7, 2019·Biomarker Research·Mingzhou GuoJames G Herman
Sep 28, 2016·Journal of Ovarian Research·Chunyan ShenKemiao Zhu
Dec 9, 2016·Open Biology·Michela FalcoClaudio Arra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.